These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2231920)

  • 21. Triamterene stone: advantage of crystallographic analysis.
    Watson RA; Ettinger B; Deshon GE; Agee RE; Oldroyd NO
    Urology; 1981 Sep; 18(3):238-40. PubMed ID: 6269267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolites.
    Werness PG; Bergert JH; Smith LH
    J Lab Clin Med; 1982 Feb; 99(2):254-62. PubMed ID: 7061920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triamterene bladder calculus.
    Hollander JB
    Urology; 1987 Aug; 30(2):154-5. PubMed ID: 3617299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triamterene and renal lithiasis: a review.
    Carey RA; Beg MM; McNally CF; Tannenbaum P
    Clin Ther; 1984; 6(3):302-9. PubMed ID: 6373008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triamterene urolithiasis.
    Gault MH; Snedden W; Taor RE; Churchill DN; Ahmed M
    Can Med Assoc J; 1981 Jun; 124(12):1556-7. PubMed ID: 7248862
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-induced renal stones: incidence, clinical expression and stone analysis.
    Rapado A; Traba ML; Caycho C; Cifuentes-Delatte L
    Contrib Nephrol; 1987; 58():25-9. PubMed ID: 2826078
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk of kidney stones.
    Ettinger B
    JAMA; 1982 Oct; 248(16):1971. PubMed ID: 7120618
    [No Abstract]   [Full Text] [Related]  

  • 28. [Triamterene induced nephrolithiasis (author's transl)].
    Lucas C; Cukier J; Daudon M; Protat MF; Reveillaud RJ
    J Urol (Paris); 1982; 88(1):37-42. PubMed ID: 7037980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triamterene and renal stone formation.
    White DJ; Nancollas GH
    J Urol; 1982 Mar; 127(3):593-7. PubMed ID: 7062445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal lithiasis medicamentosa].
    Traba ML; Rapado A; Bonet F; Cifuentes Delatte L
    Med Clin (Barc); 1984 Nov; 83(14):607-8. PubMed ID: 6513652
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of triamterene and amiloride on urinary sediment in hypertensive patients taking hydrochlorothiazide.
    Spence JD; Wong DG; Lindsay RM
    Lancet; 1985 Jul; 2(8446):73-5. PubMed ID: 2861527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triamterene and the kidney.
    Sica DA; Gehr TW
    Nephron; 1989; 51(4):454-61. PubMed ID: 2662034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric acid nephrolithiasis: An update.
    Cicerello E
    Urologia; 2018 Aug; 85(3):93-98. PubMed ID: 29687761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Incidence of drug lithiasis in 1500 cases of renal calculi].
    Traba ML; Cifuentes Delatte L; Rapado A; Caycho C; Perpiña J; Enríquez de Salamanca R
    Rev Clin Esp; 1986 Dec; 179(9):447-50. PubMed ID: 3027770
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-induced renal calculi: epidemiology, prevention and management.
    Daudon M; Jungers P
    Drugs; 2004; 64(3):245-75. PubMed ID: 14871169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irreversible renal failure associated with triamterene.
    Roy LF; Villeneuve JP; Dumont A; Dufresne LR; Duran MA; Morin C; Jobin J
    Am J Nephrol; 1991; 11(6):486-8. PubMed ID: 1819215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug-induced urinary lithiasis].
    Reveillaud RJ; Daudon M
    Presse Med; 1983 Oct; 12(38):2389-92. PubMed ID: 6138768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in stone composition over two decades: evaluation of over 10,000 stone analyses.
    Moses R; Pais VM; Ursiny M; Prien EL; Miller N; Eisner BH
    Urolithiasis; 2015 Apr; 43(2):135-9. PubMed ID: 25689875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic fate and solubility of triamterene--not an explanation for triamterene nephrolithiasis.
    Sörgel F; Ettinger B; Benet LZ
    J Pharm Sci; 1986 Feb; 75(2):129-32. PubMed ID: 3958920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.